adding mafenide only minutes following streptokinase-activated plasma or plasmin with the fibrin substrate reduced antifibrinolytic activity , supporting the conclusion that mafenide , like eaca , can modulate the interaction between fibrin and the plasmin reactive sites and thus prevent close plasmin/fibrin apposition .
C0032105
plasma
C0015982
fibrin